| Published Application/Species/Sample/Dilution | Reference |
|---|
- western blot; human; loading ...; fig 1a
| Chakraborty A, Tapryal N, Venkova T, Horikoshi N, Pandita R, Sarker A, et al. Classical non-homologous end-joining pathway utilizes nascent RNA for error-free double-strand break repair of transcribed genes. Nat Commun. 2016;7:13049 pubmed publisher |
- chromatin immunoprecipitation; human; loading ...; fig 4c
| Li G, Cunin P, Wu D, Diogo D, Yang Y, Okada Y, et al. The Rheumatoid Arthritis Risk Variant CCR6DNP Regulates CCR6 via PARP-1. PLoS Genet. 2016;12:e1006292 pubmed publisher |
- western blot; human; 1:1000; fig 5
| Xu Y, Wu D, Zheng W, Yu F, Yang F, Yao Y, et al. Proteome profiling of cadmium-induced apoptosis by antibody array analyses in human bronchial epithelial cells. Oncotarget. 2016;7:6146-58 pubmed publisher |
| Bera R, Chiu M, Huang Y, Liang D, Lee Y, Shih L. Genetic and Epigenetic Perturbations by DNMT3A-R882 Mutants Impaired Apoptosis through Augmentation of PRDX2 in Myeloid Leukemia Cells. Neoplasia. 2018;20:1106-1120 pubmed publisher |
| Chen P, Tien H, Chen S, Horng C, Tang H, Jung H, et al. Response of Myeloid Leukemia Cells to Luteolin is Modulated by Differentially Expressed Pituitary Tumor-Transforming Gene 1 (PTTG1) Oncoprotein. Int J Mol Sci. 2018;19: pubmed publisher |
| Dominguez G, Maddelein M, Pucelle M, Nicaise Y, Maurage C, Duyckaerts C, et al. Neuronal sphingosine kinase 2 subcellular localization is altered in Alzheimer's disease brain. Acta Neuropathol Commun. 2018;6:25 pubmed publisher |
| Chang H, Lu C, Chiang J, Tsai F, Juan Y, Tsao J, et al. Pterostilbene modulates the suppression of multidrug resistance protein 1 and triggers autophagic and apoptotic mechanisms in cisplatin-resistant human oral cancer CAR cells via AKT signaling. Int J Oncol. 2018;: pubmed publisher |
| Lin S, Chu P, Liao W, Wu M, Tsui K, Lin L, et al. Glycyrrhizic acid induces human MDA-MB-231 breast cancer cell death and autophagy via the ROS-mitochondrial pathway. Oncol Rep. 2018;39:703-710 pubmed publisher |
| Li S, Chen C, Chen Y, Yen Y, Fang W, Tsai F, et al. Upregulation of CISD2 augments ROS homeostasis and contributes to tumorigenesis and poor prognosis of lung adenocarcinoma. Sci Rep. 2017;7:11893 pubmed publisher |
| Lee W, Chen P, Wu W, Wu H, Lan C, Huang Y, et al. Panobinostat sensitizes KRAS-mutant non-small-cell lung cancer to gefitinib by targeting TAZ. Int J Cancer. 2017;141:1921-1931 pubmed publisher |
| Tsui K, Wang P, Lin L, Li C. DHEA protects mitochondria against dual modes of apoptosis and necroptosis in human granulosa HO23 cells. Reproduction. 2017;154:101-110 pubmed publisher |
| Lee C, Chen P, Ho K, Shih C, Cheng C, Lin C, et al. The microRNA-302b-inhibited insulin-like growth factor-binding protein 2 signaling pathway induces glioma cell apoptosis by targeting nuclear factor IA. PLoS ONE. 2017;12:e0173890 pubmed publisher |
| Liang X, Shi H, Yang L, Qiu C, Lin S, Qi Y, et al. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells. Br J Cancer. 2017;116:903-911 pubmed publisher |
| Chen P, Cheng C, Shih C, Ho K, Lin C, Lee C, et al. The Inhibition of microRNA-128 on IGF-1-Activating mTOR Signaling Involves in Temozolomide-Induced Glioma Cell Apoptotic Death. PLoS ONE. 2016;11:e0167096 pubmed publisher |
| Chen P, Chang C, Shih C, Cheng C, Lin C, Lee C, et al. The miR-204-3p-targeted IGFBP2 pathway is involved in xanthohumol-induced glioma cell apoptotic death. Neuropharmacology. 2016;110:362-375 pubmed publisher |
| Su T, Ku W, Chen H, Hsu Y, Hong Q, Chang G, et al. Oncogenic miR-137 contributes to cisplatin resistance via repressing CASP3 in lung adenocarcinoma. Am J Cancer Res. 2016;6:1317-30 pubmed |
| Shindo Y, Komatsu H, Hotta K, Ariga K, Oka K. An Artificial Reaction Promoter Modulates Mitochondrial Functions via Chemically Promoting Protein Acetylation. Sci Rep. 2016;6:29224 pubmed publisher |
| Zheng Y, Yin G, Le V, Zhang A, Chen S, Liang X, et al. Photodynamic-therapy Activates Immune Response by disrupting Immunity Homeostasis of Tumor Cells, which Generates Vaccine for Cancer Therapy. Int J Biol Sci. 2016;12:120-32 pubmed publisher |
